More News

05 Aug 2021 Rgenta Therapeutics Enters into a Collaboration with Lundbeck
05 Aug 2021 Bayer strengthens drug discovery platform through acquisition of Vividion Therapeutics
04 Aug 2021 Excel Diagnostics and Nuclear Oncology Center Announces FDA Authorization of IND for 225Ac-PSMA I&T Targeted Alpha Therapy for Castration Resistant Prostate Cancer
03 Aug 2021 Sanofi to Acquire Translate Bio; Advances Deployment of mRNA Technology across Vaccines and Therapeutics Development
02 Aug 2021 Autolus and Moderna sign Option and License Agreement for access to proprietary targeting technology from Autolus
02 Aug 2021 Ipsen and Exicure Enter Into Exclusive Collaboration Targeting Rare Neurodegenerative Disorders
31 Jul 2021 Astellas and Minovia Therapeutics Announce Strategic Collaboration for Novel Mitochondrial Cell Therapy Programs
30 Jul 2021 Alnylam and PeptiDream Enter into Collaboration Agreement to Discover and Develop Peptide-siRNA Conjugates for Targeted Delivery of RNAi Therapeutics to a Broader Range of Extrahepatic Tissues
29 Jul 2021 Lilly and Kumquat Biosciences Announce Collaboration to Discover and Develop Novel Small Molecules that Stimulate Tumor-Specific Immune Responses
28 Jul 2021 PeptiDream and Takeda Expand Collaborative Research and License Agreement to Develop Peptide Drug Conjugates for CNS Diseases
28 Jul 2021 Ipsen Strengthens Its Pre-clinical Oncology Pipeline With an Exclusive Worldwide-collaboration With BAKX Therapeutics Inc. for BKX-001, Targeting the Apoptosis Pathway
28 Jul 2021 Arena Pharmaceuticals and Aristea Therapeutics Establish Collaboration for Development of RIST4721 for Treatment of Serious Immune-Mediated Inflammatory Diseases
28 Jul 2021 AC Immune Announces Strategic Acquisition of Industry-leading Parkinson’s Disease Vaccine Candidate and Equity Investment Led by Athos Service GmbH
28 Jul 2021 AstraZeneca and Regeneron to research, develop and commercialise new small molecule medicines for obesity
27 Jul 2021 Organon and ObsEva Enter Global License Agreement to Develop and Commercialize Ebopiprant (OBE022), an Investigational Agent Being Evaluated as a First-in-Class Treatment for Preterm Labor
22 Jul 2021 Mirimus, Inc. Forms Strategic Collaboration with Biogen to Develop RNAi-Based Therapeutics for Neurological Disease Indications
21 Jul 2021 NanoSyrinx raises £6.2m to develop its synthetic biology platform for targeted intracellular engineering
20 Jul 2021 Junshi Biosciences and Immorna Announce Joint Venture to Develop Innovative Self-Replicating and Conventional mRNA Therapeutics and Vaccines
17 Jul 2021 GC LabCell and GC Cell to Merge, Creating a Premier Cell Therapy Company
16 Jul 2021 Ipsen and IRLAB Enter Exclusive Worldwide Licensing Agreement Aimed to Improve the Lives of People Living with Parkinson’s Disease
15 Jul 2021 Lilly Announces Acquisition of Protomer Technologies
13 Jul 2021 ExCellThera and Astellas enter into a license for the use of molecule UM171 in the field of pluripotent stem cells
13 Jul 2021 eTheRNA immunotherapies and Ghent University Announce mRNA Delivery Collaboration and License Agreement
13 Jul 2021 48Hour Discovery and RayzeBio Announce Strategic Research Collaboration to Discover & Develop Novel Peptide-Based Radiopharmaceuticals
13 Jul 2021 Ionis enters exclusive licensing agreement with Bicycle Therapeutics aimed at further advancing LICA technology

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up